The place of gonadotropin-releasing hormone agonists in reproductive medicine

Krasnopolskaya K.V.; Krstich E.V.; Gorskaia O.S.; Kabanova D.I.; Ashkharua T.A.

doi:https://doi.org/

Krasnopolskaya K.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii;
kafedra akusherstva i ginekologii FUV MONIKI im. M.F. Vladimirskogo

SPIN RSCI: 1252-3811
Scopus AuthorID: 57370972700
ORCID: 0000-0002-1275-9220

Krstich E.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ institut akusherstva i ginekologii

Gorskaia O.S.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ institut akusherstva i ginekologii

Kabanova D.I.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Ashkharua T.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

The place of gonadotropin-releasing hormone agonists in reproductive medicine

Authors:

Krasnopolskaya K.V., Krstich E.V., Gorskaia O.S., Kabanova D.I., Ashkharua T.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(2): 65‑67

Read: 5205 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Krasnopolskaya KV, Krstich EV, Gorskaia OS, Kabanova DI, Ashkharua TA. The place of gonadotropin-releasing hormone agonists in reproductive medicine. Russian Journal of Human Reproduction. 2012;(2):65‑67. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Age-related peculiarities of blood parameters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36

Reproductive function in patients with signs of polycystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(6):60-69

Clinical case of orphan ectopic pregnancy after in vitro fertilization. Russian Journal of Human Reproduction. 2025;(6):70-74

Comparative analysis of the effectiveness of therapy for endometrial hyperplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):75-83

The dependence of the ploidic status of embryos on the state of the spindle of oocyte division, assessed using polarization microscopy in IVF programs in women with ovarian endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49

Abstract:

Authors:

Krasnopolskaya K.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii;
kafedra akusherstva i ginekologii FUV MONIKI im. M.F. Vladimirskogo

SPIN RSCI: 1252-3811
Scopus AuthorID: 57370972700
ORCID: 0000-0002-1275-9220

Krstich E.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ institut akusherstva i ginekologii

Gorskaia O.S.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ institut akusherstva i ginekologii

Kabanova D.I.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Ashkharua T.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Close metadata

References:

Neveu S., Hedon B., Bringer J. et al. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in-vitro fertilization. Fertil Steril 1987; 47: 639.
Antoine J.M., Salat-Baroux J., Alvarez S. et al. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison. Hum Reprod 1990; 5: 5: 565-569.
Hughes E.G., Federkow D.M., Daya S. et al. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete itrafallopian transfer: a metaanalysis of randomized controlled trials. Fertil Steril 1992; 58: 888.
Hsueh A.J.W., Jones P.B.C. Extrapituitary action of gonadotropin-releasing-hormone. Endocrin Rev 1981; 2: 437-461.
Forman R.G., Frydman R., Egan D. et al. Severe hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril 1990; 53: 502-509.
Tanbo T., Dale P.O., Kjekshus E. et al. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril 1990; 53: 5: 798-803.
Homburg R., Levy T., Homburg R., Levy T., Berkovitz D. GnRH agonist reduces the miscarriage rate for pregnancies conceived in women with polycystic ovary syndrome. Fertil Steril 1993; 59: 527-531.
Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles (Cochrane review). In: the Cochrane library, issue 1. Oxford Update Software 2000.
Albuquerque L.E.T., Saconato H., Maciel M.C.R. et al. Report versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane Review. Human Reproduction Vol.18, Issue10: 2008-2017.
Kulakov V.I., Serov V.N., Abakarova P.R. i dr. Ratsional'naya farmakoterapiya v akusherstve i ginekologii: Rukovodstvo dlya praktikuyushchikh vrachei. Pod obshchei red. V.I. Kulakova, V.N. Serova. M: Litterra 2005; 1152.